AU Patent

AU2016228002A1 — Tesofensine, beta blocker combination formulation

Assigned to Saniona AS · Expires 2017-09-14 · 9y expired

What this patent protects

The present invention relates to a controlled release formulation comprising the active compounds tesofensine and a beta blocker, such as metoprolol or carvedilol, or a pharmaceutically acceptable salt thereof. The invention further relates to use of the controlled release formul…

USPTO Abstract

The present invention relates to a controlled release formulation comprising the active compounds tesofensine and a beta blocker, such as metoprolol or carvedilol, or a pharmaceutically acceptable salt thereof. The invention further relates to use of the controlled release formulation in a method of treatment of diabetes, obesity or an obesity associated disorder.

Drugs covered by this patent

Patent Metadata

Patent number
AU2016228002A1
Jurisdiction
AU
Classification
—
Expires
2017-09-14
Drug substance claim
No
Drug product claim
No
Assignee
Saniona AS
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.